NVCR logo

NovoCure Limited (NVCR) Accounts Payable

Annual Accounts Payable

$94.39 M
+$9.19 M+10.79%

31 December 2023

NVCR Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$91.32 M
+$1.15 M+1.27%

30 September 2024

NVCR Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVCR Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.8%+14.6%
3 y3 years+76.0%+52.2%
5 y5 years+253.4%+185.4%

NVCR Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+76.0%-3.3%+52.2%
5 y5 yearsat high+253.4%-3.3%+185.4%
alltimeall timeat high+840.8%-3.3%+810.2%

NovoCure Limited Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$91.32 M(+1.3%)
June 2024
-
$90.17 M(+6.9%)
Mar 2024
-
$84.32 M(-10.7%)
Dec 2023
$94.39 M(+10.8%)
$94.39 M(+18.5%)
Sept 2023
-
$79.67 M(-3.5%)
June 2023
-
$82.54 M(+1.3%)
Mar 2023
-
$81.47 M(-4.4%)
Dec 2022
$85.20 M(+17.4%)
$85.20 M(+10.6%)
Sept 2022
-
$77.03 M(-3.6%)
June 2022
-
$79.91 M(+15.5%)
Mar 2022
-
$69.19 M(-4.7%)
Dec 2021
$72.60 M(+35.3%)
$72.60 M(+21.0%)
Sept 2021
-
$60.01 M(+5.7%)
June 2021
-
$56.78 M(+7.7%)
Mar 2021
-
$52.70 M(-1.8%)
Dec 2020
$53.65 M(+45.3%)
$53.65 M(+27.1%)
Sept 2020
-
$42.21 M(+9.6%)
June 2020
-
$38.51 M(-4.7%)
Mar 2020
-
$40.41 M(+9.4%)
Dec 2019
$36.92 M
$36.92 M(+15.4%)
DateAnnualQuarterly
Sept 2019
-
$32.00 M(+6.4%)
June 2019
-
$30.07 M(+0.4%)
Mar 2019
-
$29.94 M(+12.1%)
Dec 2018
$26.71 M(+55.2%)
$26.71 M(+33.2%)
Sept 2018
-
$20.05 M(-1.9%)
June 2018
-
$20.43 M(+5.2%)
Mar 2018
-
$19.42 M(+12.9%)
Dec 2017
$17.21 M(-6.3%)
$17.21 M(+21.7%)
Sept 2017
-
$14.14 M(+7.5%)
June 2017
-
$13.16 M(-11.1%)
Mar 2017
-
$14.80 M(-19.4%)
Dec 2016
$18.36 M(+9.6%)
$18.36 M(+20.4%)
Sept 2016
-
$15.24 M(-30.7%)
June 2016
-
$22.01 M(+18.5%)
Mar 2016
-
$18.58 M(+10.9%)
Dec 2015
$16.75 M(+67.0%)
$16.75 M(+10.0%)
Sept 2015
-
$15.23 M(+13.9%)
June 2015
-
$13.38 M(+33.3%)
Dec 2014
$10.03 M(-2.5%)
$10.03 M
Dec 2013
$10.29 M
-

FAQ

  • What is NovoCure Limited annual accounts payable?
  • What is the all time high annual accounts payable for NovoCure Limited?
  • What is NovoCure Limited annual accounts payable year-on-year change?
  • What is NovoCure Limited quarterly accounts payable?
  • What is the all time high quarterly accounts payable for NovoCure Limited?
  • What is NovoCure Limited quarterly accounts payable year-on-year change?

What is NovoCure Limited annual accounts payable?

The current annual accounts payable of NVCR is $94.39 M

What is the all time high annual accounts payable for NovoCure Limited?

NovoCure Limited all-time high annual accounts payable is $94.39 M

What is NovoCure Limited annual accounts payable year-on-year change?

Over the past year, NVCR annual accounts payable has changed by +$9.19 M (+10.79%)

What is NovoCure Limited quarterly accounts payable?

The current quarterly accounts payable of NVCR is $91.32 M

What is the all time high quarterly accounts payable for NovoCure Limited?

NovoCure Limited all-time high quarterly accounts payable is $94.39 M

What is NovoCure Limited quarterly accounts payable year-on-year change?

Over the past year, NVCR quarterly accounts payable has changed by +$11.65 M (+14.62%)